Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
17.11
+0.35 (2.09%)
At close: Oct 2, 2026, 4:00 PM EDT
17.08
-0.03 (-0.18%)
After-hours: Oct 2, 2026, 4:10 PM EDT
Rallybio Market Cap
Rallybio has a market cap or net worth of $90.86 million as of October 2, 2026. Its market cap has increased by 319.05% in one year.
Market Cap
90.86M
Enterprise Value
-1.99M
1-Year Change
319.05%
Ranking
Category
Stock Price
$17.11
ChartMarket Cap Chart
Since the IPO on July 29, 2021, Rallybio's market cap has decreased from $405.60M to $90.86M, a decrease of -77.60%. That is a compound annual growth rate of -25.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 90.70M | 212.95% |
| Dec 31, 2025 | 28.98M | -27.23% |
| Dec 31, 2024 | 39.83M | -55.91% |
| Dec 29, 2023 | 90.33M | -63.67% |
| Dec 30, 2022 | 248.60M | -18.90% |
| Dec 31, 2021 | 306.52M | -24.43% |
| Jul 29, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biomea Fusion | 98.58M |
| Cardiff Oncology | 96.47M |
| NeurAxis | 96.07M |
| Nutriband | 93.60M |
| Cognition Therapeutics | 91.78M |
| Acrivon Therapeutics | 91.71M |
| ImmuCell | 88.89M |
| MediciNova | 86.63M |